GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » QLY Biotech Group Corp (OTCPK:LQLY) » Definitions » EPS (Diluted)

QLY Biotech Group (QLY Biotech Group) EPS (Diluted) : $-0.01 (TTM As of Feb. 2023)


View and export this data going back to 2021. Start your Free Trial

What is QLY Biotech Group EPS (Diluted)?

QLY Biotech Group's Earnings per Share (Diluted) for the three months ended in Feb. 2023 was $-0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2023 was $-0.01.

QLY Biotech Group's EPS (Basic) for the three months ended in Feb. 2023 was $-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2023 was $-0.01.

QLY Biotech Group's EPS without NRI for the three months ended in Feb. 2023 was $-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2023 was $-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


QLY Biotech Group EPS (Diluted) Historical Data

The historical data trend for QLY Biotech Group's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QLY Biotech Group EPS (Diluted) Chart

QLY Biotech Group Annual Data
Trend Aug19 Aug20 Aug21 Aug22
EPS (Diluted)
- - -0.01 -

QLY Biotech Group Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of QLY Biotech Group's EPS (Diluted)

For the Travel Services subindustry, QLY Biotech Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QLY Biotech Group's PE Ratio Distribution in the Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, QLY Biotech Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where QLY Biotech Group's PE Ratio falls into.



QLY Biotech Group EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

QLY Biotech Group's Diluted EPS for the fiscal year that ended in Aug. 2022 is calculated as

Diluted EPS (A: Aug. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.014-0)/3.895
=-0.00

QLY Biotech Group's Diluted EPS for the quarter that ended in Feb. 2023 is calculated as

Diluted EPS (Q: Feb. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.012-0)/3.895
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


QLY Biotech Group  (OTCPK:LQLY) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


QLY Biotech Group EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of QLY Biotech Group's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


QLY Biotech Group (QLY Biotech Group) Business Description

Traded in Other Exchanges
N/A
Address
5348 Vegas Drive, Las Vegas, NV, USA, 89108
Website
QLY Biotech Group Corp is a United States based company engaged in the tourism business.

QLY Biotech Group (QLY Biotech Group) Headlines

No Headlines